12 HR guaifenesin 835 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet
RxNorm concept 485789, clinical drug (scd). Prescribable name: guaiFENesin 835 MG / phenylephrine HCl 25 MG 12HR Extended Release Oral Tablet.
- RxCUI
- 485789
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/485789 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
12 HR guaiFENesin 835 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet; guaiFENesin 835 MG / phenylephrine HCl 25 MG 12 HR Extended Release Oral Tablet; guaifenesin 835 MG / phenylephrine HCl 25 MG 12 HR Extended Release Oral Tablet
Related concepts
- guaifenesin 835 MG (SCDC, consists of)
- phenylephrine hydrochloride 25 MG (SCDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
Linked data
NDCs
- 65224064001
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 485789 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/485789 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 485789. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.